MALLORY COOLIDGE: Open Payments
NPI 1629734751 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$219 in 14 payments from 12 companies in 2025. Trend: 2023 $185 · 2024 $176 · 2025 $219
Food & beverage: $219
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $48 |
| ABBVIE INC. | 1 | $19 |
| ABIOMED | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Verona Pharma, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
| Novo Nordisk Inc | 1 | $15 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| Amneal Pharmaceuticals LLC | 1 | $14 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: LEQVIO, VRAYLAR, GEMTESA, Ohtuvayre, JARDIANCE, Ozempic, CAPLYTA, UNITHROID.
Industry payments across NE — which companies pay providers there.
